Formal Modeling of the Key Determinants of Hepatitis C Virus (HCV) Induced Adaptive Immune Response Network: An Integrative Approach to Map the Cellular and Cytokine-Mediated Host Immune Regulations

HCV is a major causative agent of liver infection and is the leading cause of Hepatocellular carcinoma (HCC). To understand the complexity in interactions within the HCV induced immune signaling networks, a logic-based diagram is generated based on multiple reported interactions. A simple conceptual framework is presented to explore the key determinants of the immune system and their functions during HCV infection. Furthermore, an abstracted sub-network is modeled qualitatively which consists of both the key cellular and cytokine components of the HCV induced immune system. In the presence of NS5A protein of HCV, the behaviors and the interplay amongst the natural killer (NK) and T regulatory (Tregs) cells along with cytokines such as IFN-γ, IL-10, IL-12 are predicted. The overall modelling approach followed in this study comprises of prior knowledge-based logical interaction network, network abstraction, parameter estimation, regulatory network construction and analysis through state graph, enabling the prediction of paths leading to both, disease state and a homeostatic path/cycle predicted based on maximum betweenness centrality. To study the continuous dynamics of the network, Petri net (PN) model was generated. The analysis implicates the critical role of IFN-γ producing NK cells in recovery while, the role of IL-10 and IL-12 in pathogenesis. The predictive ability of the model implicates that IL-12 has a dual role under varying circumstances and leads to varying disease outcomes. This model attempts to reduce the noisy biological data and captures a holistic view of the key determinants of the HCV induced immune response.

[1]  A. Paiva,et al.  Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV , 2008, Journal of Virology.

[2]  Aamir Shafi,et al.  Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression , 2016, PeerJ.

[3]  M. Hassany,et al.  How to optimize HCV therapy in genotype 4 patients , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[4]  J. Ritz,et al.  Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. , 2000, Blood.

[5]  Carlo Ferrari,et al.  Activation of natural killer cells during acute infection with hepatitis C virus. , 2010, Gastroenterology.

[6]  T. Liang,et al.  Hepatitis C virus–like particles induce virus‐specific humoral and cellular immune responses in mice , 2001, Hepatology.

[7]  Y. Imai,et al.  Restoration of natural killer cell activity by pegylated interferon‐alpha/ribavirin therapy in chronic hepatitis C patient , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  Lisa-Ann Marie Gillings Light at the End of the Tunnel , 2016 .

[9]  C. Leonetti,et al.  Cell communication and signaling: how to turn bad language into positive one , 2019, Journal of Experimental & Clinical Cancer Research.

[10]  M. Levrero,et al.  Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question? , 2013, Gut.

[11]  T. Liang,et al.  Ribavirin improves the IFN‐γ response of natural killer cells to IFN‐based therapy of hepatitis C virus infection , 2014, Hepatology.

[12]  J. Baumbach,et al.  Modeling and analysis of innate immune responses induced by the host cells against hepatitis C virus infection. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[13]  H. Wedemeyer,et al.  Treating viral hepatitis C: efficacy, side effects, and complications , 2006, Gut.

[14]  Luay Nakhleh,et al.  The Signaling Petri Net-Based Simulator: A Non-Parametric Strategy for Characterizing the Dynamics of Cell-Specific Signaling Networks , 2008, PLoS Comput. Biol..

[15]  S. Klamt,et al.  Modeling approaches for qualitative and semi-quantitative analysis of cellular signaling networks , 2013, Cell Communication and Signaling.

[16]  Ralf Bartenschlager,et al.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.

[17]  K. Mills,et al.  Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytes , 2003, European journal of immunology.

[18]  J. Roujeau,et al.  Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. , 2012, Journal of hepatology.

[19]  D Thieffry,et al.  GINsim: a software suite for the qualitative modelling, simulation and analysis of regulatory networks. , 2006, Bio Systems.

[20]  R. Carithers,et al.  A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy , 2003, Hepatology.

[21]  H. Rosen Emerging concepts in immunity to hepatitis C virus infection. , 2013, The Journal of clinical investigation.

[22]  Thomas K. Hazlet,et al.  Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.

[23]  C. Walker,et al.  Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.

[24]  Tom C Freeman,et al.  Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation , 2017, Scientific Reports.

[25]  Francesco Pappalardo,et al.  Mathematical modeling of biological systems , 2013, Briefings Bioinform..

[26]  C. Tseng,et al.  Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.

[27]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[28]  Assieh Saadatpour,et al.  A Reduction Method for Boolean Network Models Proven to Conserve Attractors , 2013, SIAM J. Appl. Dyn. Syst..

[29]  Wolfgang Reisig,et al.  Application and Theory of Petri Nets , 1982, Informatik-Fachberichte.

[30]  J. Bohlius,et al.  Current Opinion in HIV and AIDS , 2016 .

[31]  M. Heim,et al.  Innate and adaptive immune responses in HCV infections. , 2014, Journal of hepatology.

[32]  J. Gill,et al.  Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection , 2000, Immunological reviews.

[33]  A. Gattoni,et al.  Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts). , 2006, La Clinica terapeutica.

[34]  Barbara Rehermann,et al.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.

[35]  Adrien Richard,et al.  Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. , 2004, Journal of theoretical biology.

[36]  A. Kim Hepatitis C Virus , 2016, Annals of Internal Medicine.

[37]  Jincun Zhao,et al.  Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R , 2012, PloS one.

[38]  T. Berg,et al.  Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection. , 2003, Hepato-gastroenterology.

[39]  C. Perno,et al.  Resistance to direct-acting antiviral agents: clinical utility and significance , 2015, Current opinion in HIV and AIDS.

[40]  Darius Moradpour,et al.  Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.

[41]  M. Binder,et al.  Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. , 2012, FEMS microbiology reviews.

[42]  Daniel Grant Pellicci The molecular and structural basis for antigen recognition by NKT cells , 2012 .

[43]  G. Trinchieri,et al.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. , 1998, Journal of immunology.

[44]  E. Brambilla,et al.  Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. , 2010, Journal of hepatology.

[45]  Aurélien Naldi,et al.  A Reduction of Logical Regulatory Graphs Preserving Essential Dynamical Properties , 2009, CMSB.

[46]  J. Orange,et al.  Natural killer cells inhibit hepatitis C virus expression , 2004, Journal of leukocyte biology.

[47]  Deborah Chavez,et al.  Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons , 2003, Journal of Virology.

[48]  Céline Hernandez,et al.  Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines , 2010, PLoS pathogens.

[49]  Yasmine Belkaid,et al.  Natural regulatory T cells in infectious disease , 2005, Nature Immunology.

[50]  R. Bartenschlager,et al.  Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs , 2002 .

[51]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[52]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[53]  Didier Lime,et al.  Hybrid Modelling and Dynamical Analysis of Gene Regulatory Networks with Delays , 2007, Complexus.

[54]  S. Waggoner,et al.  HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL‐12 production , 2007, Journal of leukocyte biology.

[55]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[56]  Martin Schwarick,et al.  Snoopy - A Unifying Petri Net Tool , 2012, Petri Nets.

[57]  S. Kamal,et al.  Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. , 2002, Gastroenterology.

[58]  J. Gorham Adaptive Immunity in the Liver , 2007 .

[59]  U. Niazi,et al.  Formal Modeling and Analysis of the MAL-Associated Biological Regulatory Network: Insight into Cerebral Malaria , 2012, PloS one.

[60]  Adrien Richard,et al.  Boolean Models of Biosurfactants Production in Pseudomonas fluorescens , 2012, PloS one.

[61]  Judith Nedrow Production JOURNAL OF VIROLOGY , 2011, Journal of Virology.

[62]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[63]  C. Egwuagu,et al.  Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. , 2015, Cytokine.

[64]  E. Wherry,et al.  IL-10, T cell exhaustion and viral persistence. , 2007, Trends in microbiology.

[65]  S. Waggoner,et al.  NK cells and their ability to modulate T cells during virus infections. , 2014, Critical reviews in immunology.